{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:42:53Z","timestamp":1786718573509,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Taiwan J Ophthalmol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/tjo.tjo_108_17","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T06:02:02Z","timestamp":1532930522000},"page":"93","source":"Crossref","is-referenced-by-count":17,"title":["Assessment of the optic nerve head, peripapillary, and macular microcirculation in the newly diagnosed patients with primary open-angle glaucoma treated with topical tafluprost and tafluprost\/timolol fixed combination"],"prefix":"10.4103","volume":"9","author":[{"given":"NataliaIvanovna","family":"Kurysheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2211-5056.237914-1","first-page":"767","volume-title":"Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug","author":"Takagi","year":"2004","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2211-5056.237914-2","first-page":"1271","volume-title":"Preservative-free tafluprost\/timolol fixed combination: A new opportunity in the treatment of glaucoma","author":"Konstas","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/2211-5056.237914-3","first-page":"5","volume-title":"Efficacy and tolerability of prostaglandin-timolol fixed combinations: A meta-analysis of randomized clinical trials","author":"Aptel","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/2211-5056.237914-4","first-page":"97","volume-title":"A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of tafluprost compared with latanoprost","author":"Traverso","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/2211-5056.237914-5","first-page":"24","volume-title":"Efficacy and safety of tafluprost 0.0015% versus latanoprost 0","author":"Uusitalo","year":"005","journal-title":""},{"key":"key-10.4103\/2211-5056.237914-6","first-page":"1905","volume-title":"IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma","author":"Hommer","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/2211-5056.237914-7","doi-asserted-by":"crossref","unstructured":"Pfeiffer N, Traverso CE, Lorenz K, Saarela V, Liinamaa J, Uusitalo H, et al. A6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components. Adv Ther 2014;31:1228-46.","DOI":"10.1007\/s12325-014-0163-3"},{"key":"key-10.4103\/2211-5056.237914-8","doi-asserted-by":"crossref","unstructured":"Holl\u00f3 G, Hommer A, Ant\u00f3n L\u00f3pez A, Ropo A. Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%\/timolol 0.5% versus concomitant use of the ingredients. J Ocul Pharmacol Ther 2014;30:468-75.","DOI":"10.1089\/jop.2013.0229"},{"key":"key-10.4103\/2211-5056.237914-9","first-page":"1807","volume-title":"Tafluprost\/Timolol: A review in open-angle glaucoma or ocular hypertension","author":"Hoy","year":"2015","journal-title":"Drugs"},{"key":"key-10.4103\/2211-5056.237914-10","first-page":"251","volume-title":"Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries","author":"Dong","year":"2008","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2211-5056.237914-11","first-page":"521","volume-title":"Short-term effects of topical tafluprost on retinal blood flow in cats","author":"Izumi","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/2211-5056.237914-12","first-page":"853","volume-title":"Effects of prostaglandin F(2\u03b1) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: Comparison among tafluprost, travoprost, and latanoprost","author":"Kurashima","year":"2010","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2211-5056.237914-13","first-page":"398","volume-title":"Effect of topical tafluprost on optic nerve head blood flow in patients with myopic disc type","author":"Tsuda","year":"2013","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2211-5056.237914-14","first-page":"4117","volume-title":"Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma","author":"Mayama","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2211-5056.237914-15","first-page":"181","volume-title":"Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits","author":"Akaishi","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/2211-5056.237914-16","first-page":"435874","volume-title":"Comparison of ocular pulse amplitude lowering effects of preservative-free tafluprost and preservative-free dorzolamide-timolol fixed combination eyedrops","author":"Seo","year":"2015","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/2211-5056.237914-17","first-page":"33","volume-title":"Effects of prostaglandin analogs on blood flow velocity and resistance in the ophthalmic artery of rabbits","author":"Giannico","year":"2016","journal-title":"Arq Bras Oftalmol"},{"key":"key-10.4103\/2211-5056.237914-18","first-page":"267","volume-title":"Optic nerve blood-flow abnormalities in glaucoma","author":"Flammer","year":"1998","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/2211-5056.237914-19","first-page":"609","volume-title":"The role of retrobulbar and retinal circulation on optic nerve head and retinal nerve fibre layer structure in patients with open-angle glaucoma over an 18-month period","author":"Tobe","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/2211-5056.237914-20","doi-asserted-by":"crossref","unstructured":"Mokbel TH, Ghanem AA. Diagnostic value of color Doppler imaging and pattern visual evoked potential in primary open-angle glaucoma. J Clin Exp Ophthalmol 2011;2. [Doi: 10.4172\/2155-9570.1000127].","DOI":"10.4172\/2155-9570.1000127"},{"key":"key-10.4103\/2211-5056.237914-21","doi-asserted-by":"crossref","unstructured":"Kurysheva NI, Parshunina OA, Shatalova EO, Kiseleva TN, Lagutin MB, Fomin AV. Value of structural and hemodynamic parameters for the early detection of primary open-angle glaucoma. Curr Eye Res 2016;24:1-7. [DOI: 10.1080\/02713683.2016.1184281].","DOI":"10.1080\/02713683.2016.1184281"},{"key":"key-10.4103\/2211-5056.237914-22","first-page":"716","volume-title":"Predictive value of colour Doppler imaging in a prospective study of visual field progression in primary open-angle glaucoma","author":"Mart\u00ednez","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/2211-5056.237914-23","first-page":"3127","volume-title":"Quantitative OCT angiography of optic nerve head blood flow","author":"Jia","year":"2012","journal-title":"Biomed Opt Express"},{"key":"key-10.4103\/2211-5056.237914-24","first-page":"651","volume-title":"Macula in glaucoma: Vascularity evaluated by OCT angiography","author":"Kurysheva","year":"2016","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"key-10.4103\/2211-5056.237914-25","unstructured":"Lagutin MB. Visual mathematical statistics. Naglyadnaya Matematicheskaya Statistika. Moscow: Binom; 2013."},{"key":"key-10.4103\/2211-5056.237914-26","first-page":"527","volume-title":"OCT angiography and color Doppler imaging in glaucoma diagnostics","author":"Kurysheva","year":"2017","journal-title":"J Pharm Sci Res"},{"key":"key-10.4103\/2211-5056.237914-27","first-page":"3287","volume-title":"Optical coherence tomography angiography of peripapillary retinal blood flow response to hyperoxia","author":"Pechauer","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2211-5056.237914-28","first-page":"e7","volume-title":"Influence of large intraocular pressure reduction on peripapillary OCT vessel density in ocular hypertensive and glaucoma eyes","author":"Holl\u00f3","year":"2017","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2211-5056.237914-29","first-page":"75","volume-title":"Regional comparisons of optical coherence tomography angiography vessel density in primary open-angle glaucoma","author":"Rao","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2211-5056.237914-30","first-page":"1510","volume-title":"Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension","author":"Konstas","year":"2013","journal-title":"Br J Ophthalmol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:36:49Z","timestamp":1786714609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.tjo_108_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["237914"],"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo_108_17","relation":{},"ISSN":["2211-5056"],"issn-type":[{"value":"2211-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}